APO Research
Talk to an analyst

APO RESEARCH · REPORT

Microgravity Drug Development

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Microgravity Drug Development Market Analysis and Forecast 2026-2032

4 June 2026205 pages

Choose your research edition.

Industry ResearchMicrogravity Drug Development Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Microgravity Drug Development Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Microgravity Drug Development Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Microgravity Drug Development Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Microgravity Drug Development Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Microgravity Drug Development market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Microgravity Drug Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Microgravity Drug Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Microgravity Drug Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Microgravity Drug Development is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Microgravity Drug Development include Merck, Varda Space Industries, Eli Lilly, SpaceX, Amgen and Space Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Microgravity Drug Development, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Microgravity Drug Development, also provides the revenue of main regions and countries. Of the upcoming market potential for Microgravity Drug Development, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Microgravity Drug Development revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Microgravity Drug Development market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Microgravity Drug Development revenue, projected growth trends, production technology, application and end-user industry.

Microgravity Drug Development Segment by Company

Merck

Varda Space Industries

Eli Lilly

SpaceX

Amgen

Space Pharma

Microgravity Drug Development Segment by Type

Microgravity Crystal Growth Technology

Space Cell Culture Technology

Space Omics Research

Space Bioreactor Technology

Microgravity Drug Development Segment by Application

Drug Discovery Stage

Preclinical Research Stage

Space Manufacturing Exploration Stage

Microgravity Drug Development Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microgravity Drug Development market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Microgravity Drug Development and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microgravity Drug Development.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Microgravity Drug Development in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Microgravity Drug Development company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Microgravity Drug Development revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Microgravity Drug Development Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Microgravity Crystal Growth Technology Major Player Table 3. Space Cell Culture Technology Major Player Table 4. Space Omics Research Major Player Table 5. Space Bioreactor Technology Major Player Table 6. Global Microgravity Drug Development Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Drug Discovery Stage Major Player Table 8. Preclinical Research Stage Major Player Table 9. Space Manufacturing Exploration Stage Major Player Table 10. Microgravity Drug Development Industry Trends Table 11. Microgravity Drug Development Industry Drivers Table 12. Microgravity Drug Development Industry Opportunities and Challenges Table 13. Microgravity Drug Development Industry Restraints Table 14. Global Microgravity Drug Development Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Microgravity Drug Development Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Microgravity Drug Development Market Share by Region (2021-2026) Table 17. Global Microgravity Drug Development Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Microgravity Drug Development Market Share by Region (2027-2032) Table 19. Global Microgravity Drug Development Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Microgravity Drug Development Revenue Market Share by Players (2021-2026) Table 21. Global Microgravity Drug Development Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Microgravity Drug Development Key Players Headquarters & Area Served Table 23. Global Microgravity Drug Development Players, Product Type & Application Table 24. Global Microgravity Drug Development Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Microgravity Drug Development by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Microgravity Drug Development Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Microgravity Drug Development Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Microgravity Drug Development Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Microgravity Drug Development Revenue Market Share by Type (2021-2026) Table 31. Global Microgravity Drug Development Revenue Market Share by Type (2027-2032) Table 32. Global Microgravity Drug Development Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Microgravity Drug Development Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Microgravity Drug Development Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Microgravity Drug Development Revenue Market Share by Application (2021-2026) Table 36. Global Microgravity Drug Development Revenue Market Share by Application (2027-2032) Table 37. Merck Company Information Table 38. Merck Business Overview Table 39. Merck Microgravity Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Merck Microgravity Drug Development Product Portfolio Table 41. Merck Recent Development Table 42. Varda Space Industries Company Information Table 43. Varda Space Industries Business Overview Table 44. Varda Space Industries Microgravity Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Varda Space Industries Microgravity Drug Development Product Portfolio Table 46. Varda Space Industries Recent Development Table 47. Eli Lilly Company Information Table 48. Eli Lilly Business Overview Table 49. Eli Lilly Microgravity Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Eli Lilly Microgravity Drug Development Product Portfolio Table 51. Eli Lilly Recent Development Table 52. SpaceX Company Information Table 53. SpaceX Business Overview Table 54. SpaceX Microgravity Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. SpaceX Microgravity Drug Development Product Portfolio Table 56. SpaceX Recent Development Table 57. Amgen Company Information Table 58. Amgen Business Overview Table 59. Amgen Microgravity Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Amgen Microgravity Drug Development Product Portfolio Table 61. Amgen Recent Development Table 62. Space Pharma Company Information Table 63. Space Pharma Business Overview Table 64. Space Pharma Microgravity Drug Development Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Space Pharma Microgravity Drug Development Product Portfolio Table 66. Space Pharma Recent Development Table 67. North America Microgravity Drug Development Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Microgravity Drug Development Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Microgravity Drug Development Revenue by Application (2021-2026) & (US$ Million) Table 70. North America Microgravity Drug Development Revenue by Application (2027-2032) & (US$ Million) Table 71. North America Microgravity Drug Development Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. North America Microgravity Drug Development Revenue by Country (2021-2026) & (US$ Million) Table 73. North America Microgravity Drug Development Revenue by Country (US$ Million) & (2027-2032) Table 74. Europe Microgravity Drug Development Revenue by Type (2021-2026) & (US$ Million) Table 75. Europe Microgravity Drug Development Revenue by Type (2027-2032) & (US$ Million) Table 76. Europe Microgravity Drug Development Revenue by Application (2021-2026) & (US$ Million) Table 77. Europe Microgravity Drug Development Revenue by Application (2027-2032) & (US$ Million) Table 78. Europe Microgravity Drug Development Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. Europe Microgravity Drug Development Revenue by Country (2021-2026) & (US$ Million) Table 80. Europe Microgravity Drug Development Revenue by Country (US$ Million) & (2027-2032) Table 81. China Microgravity Drug Development Revenue by Type (2021-2026) & (US$ Million) Table 82. China Microgravity Drug Development Revenue by Type (2027-2032) & (US$ Million) Table 83. China Microgravity Drug Development Revenue by Application (2021-2026) & (US$ Million) Table 84. China Microgravity Drug Development Revenue by Application (2027-2032) & (US$ Million) Table 85. Asia Microgravity Drug Development Revenue by Type (2021-2026) & (US$ Million) Table 86. Asia Microgravity Drug Development Revenue by Type (2027-2032) & (US$ Million) Table 87. Asia Microgravity Drug Development Revenue by Application (2021-2026) & (US$ Million) Table 88. Asia Microgravity Drug Development Revenue by Application (2027-2032) & (US$ Million) Table 89. Asia Microgravity Drug Development Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 90. Asia Microgravity Drug Development Revenue by Region (US$ Million) & (2021-2026) Table 91. Asia Microgravity Drug Development Revenue by Region (US$ Million) & (2027-2032) Table 92. SAMEA Microgravity Drug Development Revenue by Type (2021-2026) & (US$ Million) Table 93. SAMEA Microgravity Drug Development Revenue by Type (2027-2032) & (US$ Million) Table 94. SAMEA Microgravity Drug Development Revenue by Application (2021-2026) & (US$ Million) Table 95. SAMEA Microgravity Drug Development Revenue by Application (2027-2032) & (US$ Million) Table 96. SAMEA Microgravity Drug Development Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. SAMEA Microgravity Drug Development Revenue by Country (2021-2026) & (US$ Million) Table 98. SAMEA Microgravity Drug Development Revenue by Country (US$ Million) & (2027-2032) Table 99. Research Programs/Design for This Report Table 100. Authors List of This Report Table 101. Secondary Sources Table 102. Primary Sources List of Figures Figure 1. Microgravity Drug Development Image Figure 2. Global Microgravity Drug Development Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Microgravity Drug Development Market Size Share 2021 VS 2025 VS 2032 Figure 4. Microgravity Crystal Growth Technology Image Figure 5. Space Cell Culture Technology Image Figure 6. Space Omics Research Image Figure 7. Space Bioreactor Technology Image Figure 8. Global Microgravity Drug Development Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Microgravity Drug Development Market Size Share 2021 VS 2025 VS 2032 Figure 10. Drug Discovery Stage Image Figure 11. Preclinical Research Stage Image Figure 12. Space Manufacturing Exploration Stage Image Figure 13. Global Microgravity Drug Development Market Size (US$ Million) & (2021-2032) Figure 14. Global Microgravity Drug Development Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Microgravity Drug Development Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Microgravity Drug Development Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Microgravity Drug Development Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Microgravity Drug Development Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Microgravity Drug Development Revenue Market Share by Type (2021-2032) Figure 21. Global Microgravity Drug Development Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Microgravity Drug Development Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Microgravity Drug Development Revenue Market Share by Application (2021-2032) Figure 24. North America Microgravity Drug Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Microgravity Drug Development Revenue Share by Type (2021-2032) Figure 26. North America Microgravity Drug Development Revenue Share by Application (2021-2032) Figure 27. North America Microgravity Drug Development Revenue Share by Country (2021-2032) Figure 28. United States Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Microgravity Drug Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Microgravity Drug Development Revenue Share by Type (2021-2032) Figure 33. Europe Microgravity Drug Development Revenue Share by Application (2021-2032) Figure 34. Europe Microgravity Drug Development Revenue Share by Country (2021-2032) Figure 35. Germany Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Microgravity Drug Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Microgravity Drug Development Revenue Share by Type (2021-2032) Figure 45. China Microgravity Drug Development Revenue Share by Application (2021-2032) Figure 46. Asia Microgravity Drug Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Microgravity Drug Development Revenue Share by Type (2021-2032) Figure 48. Asia Microgravity Drug Development Revenue Share by Application (2021-2032) Figure 49. Asia Microgravity Drug Development Revenue Share by Region (2021-2032) Figure 50. Japan Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Microgravity Drug Development Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Microgravity Drug Development Revenue Share by Type (2021-2032) Figure 58. SAMEA Microgravity Drug Development Revenue Share by Application (2021-2032) Figure 59. SAMEA Microgravity Drug Development Revenue Share by Country (2021-2032) Figure 60. Brazil Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Microgravity Drug Development Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Microgravity Crystal Growth Technology
  • Space Cell Culture Technology
  • Space Omics Research
  • Space Bioreactor Technology
Applications
  • Drug Discovery Stage
  • Preclinical Research Stage
  • Space Manufacturing Exploration Stage
Companies covered
  • Merck
  • Varda Space Industries
  • Eli Lilly
  • SpaceX
  • Amgen
  • Space Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Microgravity Drug Development Market by Type
  3. 1.2.1 Global Microgravity Drug Development Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Microgravity Crystal Growth Technology
  5. 1.2.3 Space Cell Culture Technology
  6. 1.2.4 Space Omics Research
  7. 1.2.5 Space Bioreactor Technology
  8. 1.3 Microgravity Drug Development Market by Application
  9. 1.3.1 Global Microgravity Drug Development Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Drug Discovery Stage
  11. 1.3.3 Preclinical Research Stage
  12. 1.3.4 Space Manufacturing Exploration Stage
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Microgravity Drug Development Market Dynamics
  1. 2.1 Microgravity Drug Development Industry Trends
  2. 2.2 Microgravity Drug Development Industry Drivers
  3. 2.3 Microgravity Drug Development Industry Opportunities and Challenges
  4. 2.4 Microgravity Drug Development Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Microgravity Drug Development Market Perspective (2021-2032)
  2. 3.2 Global Microgravity Drug Development Growth Trends by Region
  3. 3.2.1 Global Microgravity Drug Development Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Microgravity Drug Development Market Size by Region (2021-2026)
  5. 3.2.3 Global Microgravity Drug Development Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Microgravity Drug Development Revenue by Players
  2. 4.1.1 Global Microgravity Drug Development Revenue by Players (2021-2026)
  3. 4.1.2 Global Microgravity Drug Development Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Microgravity Drug Development Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Microgravity Drug Development Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Microgravity Drug Development Key Players Headquarters & Area Served
  7. 4.4 Global Microgravity Drug Development Players, Product Type & Application
  8. 4.5 Global Microgravity Drug Development Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Microgravity Drug Development Market CR5 and HHI
  11. 4.6.3 2025 Microgravity Drug Development Tier 1, Tier 2, and Tier 3
5 Microgravity Drug Development Market Size by Type
  1. 5.1 Global Microgravity Drug Development Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Microgravity Drug Development Revenue by Type (2021-2032)
  3. 5.3 Global Microgravity Drug Development Revenue Market Share by Type (2021-2032)
6 Microgravity Drug Development Market Size by Application
  1. 6.1 Global Microgravity Drug Development Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Microgravity Drug Development Revenue by Application (2021-2032)
  3. 6.3 Global Microgravity Drug Development Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Microgravity Drug Development Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Merck Microgravity Drug Development Product Portfolio
  6. 7.1.5 Merck Recent Developments
  7. 7.2 Varda Space Industries
  8. 7.2.1 Varda Space Industries Company Information
  9. 7.2.2 Varda Space Industries Business Overview
  10. 7.2.3 Varda Space Industries Microgravity Drug Development Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Varda Space Industries Microgravity Drug Development Product Portfolio
  12. 7.2.5 Varda Space Industries Recent Developments
  13. 7.3 Eli Lilly
  14. 7.3.1 Eli Lilly Company Information
  15. 7.3.2 Eli Lilly Business Overview
  16. 7.3.3 Eli Lilly Microgravity Drug Development Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eli Lilly Microgravity Drug Development Product Portfolio
  18. 7.3.5 Eli Lilly Recent Developments
  19. 7.4 SpaceX
  20. 7.4.1 SpaceX Company Information
  21. 7.4.2 SpaceX Business Overview
  22. 7.4.3 SpaceX Microgravity Drug Development Revenue and Gross Margin (2021-2026)
  23. 7.4.4 SpaceX Microgravity Drug Development Product Portfolio
  24. 7.4.5 SpaceX Recent Developments
  25. 7.5 Amgen
  26. 7.5.1 Amgen Company Information
  27. 7.5.2 Amgen Business Overview
  28. 7.5.3 Amgen Microgravity Drug Development Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Amgen Microgravity Drug Development Product Portfolio
  30. 7.5.5 Amgen Recent Developments
  31. 7.6 Space Pharma
  32. 7.6.1 Space Pharma Company Information
  33. 7.6.2 Space Pharma Business Overview
  34. 7.6.3 Space Pharma Microgravity Drug Development Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Space Pharma Microgravity Drug Development Product Portfolio
  36. 7.6.5 Space Pharma Recent Developments
8 North America
  1. 8.1 North America Microgravity Drug Development Revenue (2021-2032)
  2. 8.2 North America Microgravity Drug Development Revenue by Type (2021-2032)
  3. 8.2.1 North America Microgravity Drug Development Revenue by Type (2021-2026)
  4. 8.2.2 North America Microgravity Drug Development Revenue by Type (2027-2032)
  5. 8.3 North America Microgravity Drug Development Revenue Share by Type (2021-2032)
  6. 8.4 North America Microgravity Drug Development Revenue by Application (2021-2032)
  7. 8.4.1 North America Microgravity Drug Development Revenue by Application (2021-2026)
  8. 8.4.2 North America Microgravity Drug Development Revenue by Application (2027-2032)
  9. 8.5 North America Microgravity Drug Development Revenue Share by Application (2021-2032)
  10. 8.6 North America Microgravity Drug Development Revenue by Country
  11. 8.6.1 North America Microgravity Drug Development Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Microgravity Drug Development Revenue by Country (2021-2026)
  13. 8.6.3 North America Microgravity Drug Development Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Microgravity Drug Development Revenue (2021-2032)
  2. 9.2 Europe Microgravity Drug Development Revenue by Type (2021-2032)
  3. 9.2.1 Europe Microgravity Drug Development Revenue by Type (2021-2026)
  4. 9.2.2 Europe Microgravity Drug Development Revenue by Type (2027-2032)
  5. 9.3 Europe Microgravity Drug Development Revenue Share by Type (2021-2032)
  6. 9.4 Europe Microgravity Drug Development Revenue by Application (2021-2032)
  7. 9.4.1 Europe Microgravity Drug Development Revenue by Application (2021-2026)
  8. 9.4.2 Europe Microgravity Drug Development Revenue by Application (2027-2032)
  9. 9.5 Europe Microgravity Drug Development Revenue Share by Application (2021-2032)
  10. 9.6 Europe Microgravity Drug Development Revenue by Country
  11. 9.6.1 Europe Microgravity Drug Development Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Microgravity Drug Development Revenue by Country (2021-2026)
  13. 9.6.3 Europe Microgravity Drug Development Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Microgravity Drug Development Revenue (2021-2032)
  2. 10.2 China Microgravity Drug Development Revenue by Type (2021-2032)
  3. 10.2.1 China Microgravity Drug Development Revenue by Type (2021-2026)
  4. 10.2.2 China Microgravity Drug Development Revenue by Type (2027-2032)
  5. 10.3 China Microgravity Drug Development Revenue Share by Type (2021-2032)
  6. 10.4 China Microgravity Drug Development Revenue by Application (2021-2032)
  7. 10.4.1 China Microgravity Drug Development Revenue by Application (2021-2026)
  8. 10.4.2 China Microgravity Drug Development Revenue by Application (2027-2032)
  9. 10.5 China Microgravity Drug Development Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Microgravity Drug Development Revenue (2021-2032)
  2. 11.2 Asia Microgravity Drug Development Revenue by Type (2021-2032)
  3. 11.2.1 Asia Microgravity Drug Development Revenue by Type (2021-2026)
  4. 11.2.2 Asia Microgravity Drug Development Revenue by Type (2027-2032)
  5. 11.3 Asia Microgravity Drug Development Revenue Share by Type (2021-2032)
  6. 11.4 Asia Microgravity Drug Development Revenue by Application (2021-2032)
  7. 11.4.1 Asia Microgravity Drug Development Revenue by Application (2021-2026)
  8. 11.4.2 Asia Microgravity Drug Development Revenue by Application (2027-2032)
  9. 11.5 Asia Microgravity Drug Development Revenue Share by Application (2021-2032)
  10. 11.6 Asia Microgravity Drug Development Revenue by Country
  11. 11.6.1 Asia Microgravity Drug Development Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Microgravity Drug Development Revenue by Country (2021-2026)
  13. 11.6.3 Asia Microgravity Drug Development Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Microgravity Drug Development Revenue (2021-2032)
  2. 12.2 SAMEA Microgravity Drug Development Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Microgravity Drug Development Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Microgravity Drug Development Revenue by Type (2027-2032)
  5. 12.3 SAMEA Microgravity Drug Development Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Microgravity Drug Development Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Microgravity Drug Development Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Microgravity Drug Development Revenue by Application (2027-2032)
  9. 12.5 SAMEA Microgravity Drug Development Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Microgravity Drug Development Revenue by Country
  11. 12.6.1 SAMEA Microgravity Drug Development Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Microgravity Drug Development Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Microgravity Drug Development Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst